1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. South Carolina >
  6. Donaldson Acquires Purilogics

M&A Deal Summary

Donaldson Acquires Purilogics

On June 14, 2022, Donaldson acquired life science company Purilogics

Acquisition Highlights
  • This is Donaldson’s 1st transaction in the Life Science sector.
  • This is Donaldson’s 9th transaction in the United States.
  • This is Donaldson’s 1st transaction in South Carolina.

M&A Deal Summary
Date 2022-06-14
Target Purilogics
Sector Life Science
Buyer(s) Donaldson
Deal Type Add-on Acquisition

Target

Purilogics

Greenville, South Carolina, United States
Purilogics is an early-stage biotechnology company that leverages a novel technology platform for the development of best-in-class membrane chromatography products. The company offers a broad portfolio of purification tools for a wide range of biologics, including mRNA, plasmid DNA, viral particles, monoclonal antibodies, and proteins. Its proprietary formulations and processes create membranes that have significant competitive advantages, enabling faster and more cost-effective production of increasingly complex biologic drugs. Purilogics was formed in 2013 and is based in Greenville, South Carolina.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Donaldson

Bloomington, Minnesota, United States
Category Company
Founded 1915
Sector Machinery
Employees14,000
Revenue 3.6B USD (2024)
DESCRIPTION
Donaldson's corporate headquarters in Minneapolis, Minnesota.
Donaldson's corporate headquarters in Minneapolis, Minnesota.

Donaldson is a provider of filtration systems and replacement parts. Donaldson is a technology-driven company committed to satisfying customer needs for filtration solutions through innovative research and development. Donaldson was incorporated in 1915 and is based in Bloomington, Minnesota.

DEAL STATS #
Overall 14 of 17
Sector: Life Science M&A 1 of 3
Type: Add-on Acquisition M&A Deals 11 of 13
State: South Carolina M&A 1 of 1
Country: United States M&A 9 of 10
Year: 2022 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-11-23 Solaris

Mantua, Italy

Solaris designs and manufactures bioprocessing equipment, including bioreactors, fermenters, and tangential flow filtration systems for use in food and beverage, biotechnology, and other life sciences markets. Solaris’ product portfolio ranges from benchtop systems for research and development to pilot and commercial-scale manufacturing systems. Solaris is based in Mantua, Italy.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2023-02-21 Isolere

Research Triangle Park, North Carolina, United States

Isolere is an early-stage biotechnology company that develops novel and proprietary IsoTag reagents and accompanying filtration processes used for the purification and streamlined manufacturing of biopharmaceuticals. Its reagents are designed to substantially improve product quality and purity with faster timelines compared to competing solutions, enabling accelerated and more affordable delivery of life-changing therapies to patients globally. Isolere is based in Research Triangle Park, North Carolina.

Buy -
Mergr

Solution for

Product

Company

Legal